Mylan To Buy Abbott Business Line In $5.3B Deal

Now watching

Next video starts in : 7 Play

Mylan To Buy Abbott Business Line In $5.3B Deal

Mylan To Buy Abbott Business Line In $5.3B Deal
Replay video
Up next

AirAsia Plane Carrying 162 Lost; 3rd Malaysia Airline Shock

Unlock your personal NFL Now stream by signing in to NFL.com

Mylan To Buy Abbott Business Line In $5.3B Deal

by Wochit 0:50 mins

Mylan To Buy Abbott Business Line In $5.3B Deal

by Wochit 0:50 mins

The generic drugmaker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion. Mylan says the deal will diversify and expand its business outside the U.S. The combined company will be organized in the Netherlands and headquartered in Pittsburgh, which help reduce tax expenses. The business to be acquired encompasses generic and specialty drugs sold in Europe, Japan, Canada, Australia and New Zealand. Abbott will own about 21% of the combined Mylan company but does not intend to remain a long-term shareholder. The deal is expected to close in early 2015. Mylan is based in Canonsburg, just outside of Pittsburgh.

Wochit

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 0:29

    Watch a Sneak Peek of Community Episode 4

  5. 2:01

    Sin City Saints: Official Trailer